Nicotinic receptors, nucleus accumbens and attention deficit hyperactivity disorder;Nikotinik reseptörler, nükleus akumbens ve dikkat eksikliǧi hiperaktivite bozukluǧu

Klinik Psikofarmakoloji Bulteni

Volumn 18, Issue 2, 2008, Pages 122-129

  Karabekiroǧlu, Koray ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

ADHD; Cigarette smoking; Nicotinic receptors; Nucleus accumbens; Pregnancy

Indexed keywords

DOPAMINE; GLUTAMIC ACID; NICOTINIC RECEPTOR; NORADRENALIN;

ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN FUNCTION; DISEASE ASSOCIATION; HUMAN; NUCLEUS ACCUMBENS; OUTCOME ASSESSMENT; RISK FACTOR; TOBACCO DEPENDENCE;

EID: 46349105745     PISSN: 10177833     EISSN: 13029657     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Paterson D, Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol 2000, 61(1):75-111
2. Gotti C, Clementi F Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 2004; 74:363-396
3. Nordberg A. The nicotinic receptors in the human brain. Eur Neuropsychopharm 2002: S85
4. Svensson TH. Effects of nicotine on the mesolimbic dopaminergic reward system in brain. Eur Neuropsychopharm 2002;12:S86
5. Sachs DPL. Clinical symptomatology of nicotine withdrawal and its control in humans. Eur Neuropsychopharm 2002; 12: S87
6. Hohnadel EJ, Hernandez CM, Gearhart DA, Terry Jr. AV Effect of repeated nicotine exposure on high-affinity nicotinic acetylcholine receptor density in spontaneously hypertensive rats. Neurosci Lett 2005, 382:158-163
7. Brennan PA, Grekin ER, Mednick SA. Maternal smoking during pregnancy and adult male criminal outcomes. Arch Gen Psychiatry 1999; 56:215-219
8. Orlebeke JF; Knol DL; Verhulst FC Increase in child behavior problems resulting from maternal smoking during pregnancy. Arch Environ Health 1997; 52(4): 317-321
9. Orlebeke JF, Knol DL, Verhulst FC. Child behavioral problems increased by maternal smoking during pregnancy. Arch Environ Health 1999; 54:15-19
10. Rasanen P, Hakko H, Isohanni M, Hodgkins S, Jarvelin MR, Tiihonen J. Maternal smoking during pregnancy and risk of criminal behavior among adult male offspring in the Northern Finland 1966 Birth Cohort. Am J Psychiatry 1999; 156:857-862
11. Wakschlag LS, Lahey BB, Loeber R, Gren SM, Gordon RA, Leventhal BL. Maternal smoking during pregnancy and the risk of conduct disorder in boys. Arch Gen Psychiatry 1997; 54:670-676
12. Weitzman M, Gortmaker S, Sobol A. Maternal smoking and behavioral problems of children. Pediatrics 1992; 90:342-349
13. Picciotto MR, Caldarone BJ, King SL, Zachariou V. Nicotinic receptors in the brain: links between molecular biology and behavior. Neuropsychopharmacol 2000; 22:451-465
14. Mansvelder HD, McGehee D. Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 2002;53:606-617
15. Picciotto M. Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci 2003; 23:494-499
16. Gentry CL, Lukas R. Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr Drugs Targets CNS Neurol Dis 2002; 1:359-385
17. Sacco KA, Bannon KL, George TP Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol 2004, 18(4): 457-474
18. Granon S, Changeux JP Attention-deficit/hyperactivity disorder: A plausible mouse model Acta Paediatr. 2006; 95(6):645-659
19. Ernst M, Moolchan ET, Robinsin ML. Behavioral and Neural Consequences of Prenatal Exposure to Nicotine. J Am Acad Child Adolesc Psychiatry 2001; 40(6):630-641
20. Nordberg A, Zhang XA, Fredericson A, Eriksson P. Neonatal nicotine exposure induces permenant changes in brain nicotinic receprors and behavior in adult mice. Brain Res Dev 1991; 63:201-207
21. Yanai J, Pick CG,Rogel-Fuchs Y, Zahalka EA. Alterations in hippocampal cholinergic receptors and hippocampal behaviors after early exposure to nicotine. Brain Res Bull 1992; 29:363-368
22. Gusella JL, Fried PA. Effects of maternal social drinking and smoking on offspring at 13 months. Neurobehav Toxicol Teratol 1984; 6:13-17
23. Saxton DW. The behavior of infants whose mother smoke in pregnancy. Early Hum Dev 1978; 2:363-369
24. Fung YK, Lau YS. Receptor mechanisms of nicotine-induced locomotor hyperactivity in chronic nicotine-treated rats. Eur J Pharmacol 1998; 152: 263-271
25. Fried PA, Watkinson B, Gray R. A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marihuana, cigarettes, and alcohol. Neurotoxicol Teratol 1992; 14:299-311
26. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am J Psychiatry 1996; 153:1138-1142
27. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 1997; 36:37-44
28. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. Further evidence of an association between attention-deficit/hyperactivity disorder and cigarette smoking: findings from a high-risk sample of siblings. Am J Addict 1997; 6:205-217
29. Milberger S, Biederman J, Faraone SV, Jones J. Further evidence of an association between attention-deficit/hyperactivity disorder and cigarette smoking: findings from a high-risk sample of siblings. J Clin Child Psychol 1998, 27:352-358
30. Tizabi Y, Popke EJ, Rahman MA, Nespor SM, Grunberg NE. Hyperactivity induced by prenatal nicotine exposure is associated with an increase in cortical nicotine receptors. Pharmacol Biochem Behav 1997, 58:141-146
31. Schweitzer J, Anderson C, Ernst M. Attention deficit hyperactivity disorder: neoroimaging and behavioral/cognitive probes; Functional Neoroimaging in Child Psychiatry Cambridge University Pres, 2000, pp.278-297
32. Navarro HA, Seidler FJ, Schwartz RD, Baker FE, Dobbins SS, Slotkin TA. Prenatal exposure to nicotine impairs nervous system development at a dose which dose not affect viability or growth. Brain Res Bull 1989, 23:187-192
33. Tizabi Y; Russell LT; Nespor SM; Perry DC; Grunberg NE. Prenatal nicotine exposure: effects on locomotor activity and central [125I]alpha-BT binding in rats. Pharmacol Biochem Behav 2000; 66(3): 495-500
34. Haber SN, Fudge JL, McFarland NR. Striatonigral pathways in primates form an ascending spiral from the shell to the dorsal striatum. J Neurosci 2000; 20:2369-2382
35. Marshall D. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated animals. J Neurochem 1997; 68:1511-1519
36. George TP, Vessicchio JC, Termine A, Sahady DM, Head CA, Pepper WT, Kosten TR, Wexler B. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacol 2002; 26:75-85
37. Russell V. In vitro glutamate-stimulated release of dopamine from nucleus accumbens core and shell of spontaneously hypertensive rats. Metab Brain Dis 2003; 18:161-168
38. Fujita S, Okutsu H, Yamaguchi H, Nakamura S, Adachi K, Saigusa T, Koshikawa N. Altered pre- and postsynaptic dopamine receptor functions in spontaneously hypertensive rat: an animal model of attention-deficit hyperactivity disorder. J Oral Sci 2003; 45:75-83
39. Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res 2000;126:325-341
40. Cardinal RN, Winstanley CA, Robbins TW, Everitt BJ. Limbic corticostriatal systems and delayed reinforcement. Ann N Y Acad Sci 2004;1021:33-50
41. American Psychiatric Assossiation (APA). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington DC: American Psychiatric Assossiation, 1994
42. Russell V. Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder--the spontaneously hypertensive rat. Neurosci Biobehav Rev 2003; 27:671-682
43. Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N, Waldman I, Fitzgerald M, Gill M. Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacol 2002; 27:607-619
44. Papa M, Sergeant JA, Sadile AG. Differential expression of transcription factors in the accumbens of an animal model of ADHD. Neuroreport 1997; 8:1607-1612
45. Grace AA. Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Rev 2000; 31:330-341
46. Sagvolden T, Sergeant JA. Attention deficit/hyperactivity disorder-from brain dysfunctions to behaviour. Behav Brain Res 1998; 94:1-10
47. Tarazi FI, Campbell A, Yeghiayan SK, Baldessarini RJ. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors. Neuroscience 1998; 83:169-176
48. O'Donnell P, Grace AA. Phencyclidine interferes with the hippocampal gating of nucleus accumbens neuronal activity in vivo. Neuroscience 1998; 87:823-830
49. Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry 2002; 41:378-385
50. Bonci A, Bernardi G, Grillner P, Mercuri NB. The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction? TIPS 24 2003:172-177
51. Carlezon WA, Nestler EJ. Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? TINS 25 2002: 610-615
52. Sonuga-Barke EJ, Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways Biol Psychiatry 2000; 57:1231-1238
53. Sonuga-Barke EJ, The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev 2003; 27:593-604
54. Levy F. Synaptic gating and ADHD: a biological theory of comorbidity of ADHD and anxiety. Neuropsychopharmacology. 2004; 29:1589-1596
55. Chase TD, Carrey N, Brown RE, Wilkinson M. Methylphenidate regulates c-fos and fosB expression in multiple regions of the immature rat brain. Brain Res Dev Brain Res 2005; 156:1-12
56. Levin ED, Mead T, Rezvani AH, Rose JE, Gallivan C, Gross R. The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats. Physiol Behav 2000; 71:565-570
57. Shytle RD, Silver AA, Wilkinson BJ, Sanberg P. A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorder. World J Biol Psychiatry 2002; 3:150-155
58. Wilens TE, Biederman J, Spencer TJ, Bostic J, Prince J, Monuteaux MC, Soriano J, Fine C, Abrams A, Rater M, Pulisner D. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry 1999;156:1931-1937
59. Levin ED Nicotinic receptor subtypes and cognitive function. J Neurobiol 2002; 53:633-640
60. Lippiello PM, Nicotinic cholinergic antagonists: A novel approach for the treatment of autism Med Hypotheses 2006; 66:985-990
61. Newhouse PA, Potter A, Singh A. Effects of nicotinic stimulation on cognitive performance Curr Opin Pharmacol 2004; 4:36-46
62. Rezvani AH, Levin ED Nicotine mechanisms in Alzheimer's disease Cognitive effects of nicotine Biol Psychiatry 2001; 49:258-267
63. Dubrovsky BO. Steroids, neuroactive steroids and neurosteroids in psychopathology Progress in Neuro-Psychopharmacology and Biol Psychiatry 2005; 29: 169-192